phase readout
saveNCT07232576: A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE2. Conditions: Adult Patients With Moderately to Severely Active Ulcerative Colitis
view source ↗
comments(0)
5-min edit window · permanent after that